As inflammation can promote tumor progression [42] and AdipoQ exerts anti‐inflammatory effects [43], we investigated whether sST2‐knockdown tumors exhibited a heightened inflammatory state compared with that of Panc02‐shCont tumors by assessing the activation of NF‐κB, a master regulator of inflammation and immune homeostasis [44]. Here, ADIPOQ is linked to neoplasm.